| 前收市價 | 7.30 |
| 開市 | 無 |
| 買盤 | 4.60 |
| 賣出價 | 8.40 |
| 拍板 | 55.00 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 7.30 - 7.30 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 50 |
Motley FoolWhere Will Novavax Be in 1 Year?
We will know a lot more about the vaccine maker's long-term prospects in 12 months.
BloombergSanofi Seeks Initial Offers for Its $20 Billion Consumer Arm
(Bloomberg) -- Sanofi SA has called for initial bids for its $20 billion consumer health division, as the French pharmaceutical giant simultaneously moves forward with preparations for a possible listing of the business, according to people familiar with the matter. Most Read from BloombergYouTuber Dr Disrespect Was Allegedly Kicked Off Twitch for Messaging MinorTrump Could Actually Lose Florida. Here’s Why.Volkswagen Invests $5 Billion in EV Startup Rivian to Form Joint VentureNvidia Rout Takes
ZacksNovavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
